These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Images of an occlusive arterial disease of lower extremity due to chronic intoxication by ergot alkaloid. Baudoin Y, Guilhem K, Meyrat L, Thouard H. J Vasc Surg; 2014 Sep; 60(3):785. PubMed ID: 25154965 [No Abstract] [Full Text] [Related]
25. [Study on the efficacy of ginkgo biloba extract, magnesium and levo-arginine in the treatment of patients with 2d stage arteriopathies. A preliminary study]. Michelini S, Micci A, Failla A, Moneta G, Ottaviani A. Minerva Cardioangiol; 1998 Sep; 46(9):319-20. PubMed ID: 10021862 [No Abstract] [Full Text] [Related]
26. Clopidogrel and [symbol: see text] ticlopidine--improvements on aspirin? Drug Ther Bull; 1999 Aug; 37(8):59-61. PubMed ID: 10696686 [Abstract] [Full Text] [Related]
27. Therapeutic effect of ticlopidine for ischemic leg ulcers. Katsumura T. Agents Actions Suppl; 1984 Aug; 15():167-72. PubMed ID: 6385645 [No Abstract] [Full Text] [Related]
28. [Critical ischemia in elderly patients. Evaluation of the effect of two different methods of Iloprost therapy on the efficacy, tolerance, modification of quality of life and self-sufficiency]. Cappelli R, Bicchi M, Arrigucci S, Boschi S, Guerrini M, Forconi S. Minerva Cardioangiol; 1999 Mar; 47(3):81-8. PubMed ID: 10389449 [Abstract] [Full Text] [Related]
29. [Application of preparation endotelon in complex treatment of chronic arterial insufficiency of lower extremities]. Gusak VK, Shtutin AA, Rodin IuV, Il'iushchenko SV, Iurchuk AIu. Klin Khir; 2000 Oct; (10):7-9. PubMed ID: 11247442 [Abstract] [Full Text] [Related]
31. [The drug prevention of postoperative thromboses in patients with critical lower limb ischemia]. Kobza II. Lik Sprava; 1999 Jul; (5):68-70. PubMed ID: 10822682 [Abstract] [Full Text] [Related]
35. [Role and place of prolonged intra-arterial infusion in the treatment of obliterating arterial diseases of the lower extremities]. Belichenko IA, Kungurtsev VV, Dibirov MD. Khirurgiia (Mosk); 1980 Mar; (3):48-51. PubMed ID: 7366097 [No Abstract] [Full Text] [Related]
38. [The use of Vasaprostan (prostaglandin E1) in treating patients with obliterating arterial diseases of the lower extremities]. Lebedev LV, Afonin DN. Vestn Khir Im I I Grek; 1993 Jun; 150(5-6):153-7. PubMed ID: 8091569 [No Abstract] [Full Text] [Related]